Prospect Capital Corporation: Wells Fargo cuts target price to $1.5 from $2
PSEC•Wells Fargo cut its target price for Prospect Capital Corporation to $1.5 from $2.
Related News
Vistra Q3 revenue $6,347 million vs. IBES estimate $6,024 million
VST•
Bausch Health study estimates 62% one-year survival in severe alcohol-associated hepatitis patients
BHC•
Ocular Therapeutix grants equity awards to eight newly hired employees
OCUL•
Brookfield Asset Management Q3 non-GAAP fee-related earnings rise 15% to USD 864 million
BAM•
Korro Bio to present at Jefferies Global Healthcare Conference
KRRO•